NCT02996825
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Phase 1
Drug Category: Therapeutic Antibody, Chemotherapy

Key Eligibility Criteria:

Gender: All
Age: Child, Adult), Senior)
Location of Metastases: 
Additional Notes: 
Exclusions: Patients with known brain metastases
https://ClinicalTrials.gov/show/NCT02996825